Browse by UCL people
Group by: Type | Date
Number of items: 119.
2024
Emmenegger, Tim M;
Pfyffer, Dario;
Curt, Armin;
Schading-Sassenhausen, Simon;
Hupp, Markus;
Ashburner, John;
Friston, Karl;
... Freund, Patrick; + view all
(2024)
Longitudinal motor system changes from acute to chronic spinal cord injury.
European Journal of Neurology
, Article e16196. 10.1111/ene.16196.
(In press).
|
Wright, Sarah L;
Thompson, Alan J;
(2024)
Managing patients with late-onset neutropenia during treatment with ocrelizumab.
Multiple Sclerosis Journal
, 30
(1)
10.1177/13524585231206219.
|
2023
Azzarito, Michela;
Emmenegger, Tim;
Ziegler, Gabriel;
Huber, Eveline;
Grabher, Patrick;
Callaghan, Martina F;
Thompson, Alan;
... Freund, Patrick; + view all
(2023)
Coherent, time-shifted patterns of microstructural plasticity during motor-skill learning.
Neuroimage
, 274
, Article 120128. 10.1016/j.neuroimage.2023.120128.
|
Ciccarelli, Olga;
Toosy, Ahmed T;
Thompson, Alan;
Hacohen, Yael;
(2023)
Navigating Through the Recent Diagnostic Criteria for MOGAD: Challenges and Practicalities.
Neurology
, 100
(15)
pp. 689-690.
10.1212/WNL.0000000000207238.
|
Kuhlmann, T;
Moccia, M;
Coetzee, T;
Cohen, JA;
Correale, J;
Graves, J;
Marrie, RA;
... International Advisory Committee on Clinical Trials in Multiple, .; + view all
(2023)
Multiple sclerosis progression: time for a new mechanism-driven framework.
The Lancet Neurology
, 22
(1)
pp. 78-88.
10.1016/S1474-4422(22)00289-7.
|
Müller, Jannis;
Cagol, Alessandro;
Lorscheider, Johannes;
Tsagkas, Charidimos;
Benkert, Pascal;
Yaldizli, Özgür;
Kuhle, Jens;
... Kappos, Ludwig; + view all
(2023)
Harmonizing Definitions for Progression Independent of Relapse Activity in Multiple Sclerosis: A Systematic Review.
JAMA Neurology
10.1001/jamaneurol.2023.3331.
(In press).
|
Sahi, Nitin;
Haider, Lukas;
Chung, Karen;
Prados Carrasco, Ferran;
Kanber, Baris;
Samson, Rebecca;
Thompson, Alan J;
... Chard, Declan; + view all
(2023)
Genetic influences on disease course and severity, 30 years after a clinically isolated syndrome.
Brain Communications
, 5
(5)
, Article fcad255. 10.1093/braincomms/fcad255.
|
Schading, Simon;
David, Gergely;
Max Emmenegger, Tim;
Achim, Cristian;
Thompson, Alan;
Weiskopf, Nikolaus;
Curt, Armin;
(2023)
Dynamics of progressive degeneration of major spinal pathways following spinal cord injury: A longitudinal study.
NeuroImage: Clinical
, 37
, Article 103339. 10.1016/j.nicl.2023.103339.
|
Selmaj, Krzysztof;
Cree, Bruce AC;
Barnett, Michael;
Thompson, Alan;
Hartung, Hans-Peter;
(2023)
Multiple sclerosis: time for early treatment with high-efficacy drugs.
Journal of Neurology
10.1007/s00415-023-11969-8.
|
Thompson, Alan J;
Moccia, Marcello;
Amato, Maria Pia;
Calabresi, Peter A;
Finlayson, Marcia;
Hawton, Annie;
Lublin, Fred D;
... Coetzee, Timothy; + view all
(2023)
Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community.
Multiple Sclerosis Journal
10.1177/13524585231196786.
(In press).
|
2022
Freund, Patrick;
Papinutto, Nico;
Bischof, Antje;
Azzarito, Michela;
Kirkish, Gina;
Ashburner, John;
Thompson, Alan;
... Henry, Roland G; + view all
(2022)
Simultaneous assessment of regional distributions of atrophy across the neuraxis in MS patients.
NeuroImage: Clinical
, 34
, Article 102985. 10.1016/j.nicl.2022.102985.
|
Zabalza, Ana;
Thompson, Alan J;
Montalban, Xavier;
(2022)
Two years of COVID-19 in the MS community: What have we learnt so far?
Multiple Sclerosis Journal
, 28
(7)
, Article 13524585221099844. 10.1177/13524585221099844.
|
2021
David, G;
Pfyffer, D;
Vallotton, K;
Pfender, N;
Thompson, A;
Weiskopf, N;
Mohammadi, S;
... Freund, P; + view all
(2021)
Longitudinal changes of spinal cord grey and white matter following spinal cord injury.
Journal of Neurology, Neurosurgery and Psychiatry
, 92
(11)
pp. 1222-1230.
10.1136/jnnp-2021-326337.
|
Eshaghi, A;
Young, A;
Wijeratne, PA;
Prados, F;
Arnold, DL;
Narayanan, S;
Guttmann, CRG;
... Ciccarelli, O; + view all
(2021)
Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data.
Nature Communications
, 12
, Article 2078. 10.1038/s41467-021-22265-2.
|
Haider, L;
Prados Carrasco, F;
Chung, K;
Goodkin, O;
Kanber, B;
Sudre, C;
Yiannakas, M;
... Barkhof, F; + view all
(2021)
Cortical involvement determines impairment 30 years after a clinically isolated syndrome.
Brain
, 144
(5)
pp. 1384-1395.
10.1093/brain/awab033.
|
Hartung, H-P;
Meuth, SG;
Thompson, A;
(2021)
Paradigm shifts: Early initiation of high efficacy disease modifying treatment in Multiple Sclerosis.
Multiple Sclerosis Journal
(In press).
|
Thompson, A;
Carroll, W;
Ciccarelli, O;
Comi, G;
Cross, A;
Donnelly, A;
Feinstein, A;
... Hyde, R; + view all
(2021)
Charting a Global Research Strategy for Progressive MS – An International Progressive MS Alliance Proposal.
Multiple Sclerosis Journal
(In press).
|
Tur, C;
Grussu, F;
De Angelis, F;
Prados, F;
Kanber, B;
Calvi, A;
Eshaghi, A;
... Gandini Wheeler-Kingshott, CAM; + view all
(2021)
Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS technique.
NeuroImage: Clinical
, 33
, Article 102904. 10.1016/j.nicl.2021.102904.
|
2020
Abdel-Mannan, O;
Cortese, R;
Wassmer, E;
Hemingway, C;
Thompson, A;
Brownlee, W;
Ciccarelli, O;
(2020)
Primary progressive multiple sclerosis presenting under the age of 18 years: fact or fiction?
Multiple Sclerosis Journal
(In press).
|
Arrambide, G;
Iacobaeus, E;
Amato, MP;
Derfuss, T;
Vukusic, S;
Hemmer, B;
Brundin, L;
... 2018 ECTRIMS Focused Workshop Group; + view all
(2020)
Aggressive multiple sclerosis (2): Treatment.
Multiple Sclerosis Journal
, 26
(9)
pp. 1045-1063.
10.1177/1352458520924595.
|
Charalambous, T;
Clayden, JD;
Powell, E;
Prados, F;
Tur, C;
Kanber, B;
Chard, D;
... Toosy, AT; + view all
(2020)
Disrupted principal network organisation in multiple sclerosis relates to disability.
Scientific Reports
, 10
, Article 3620. 10.1038/s41598-020-60611-4.
|
Chung, KK;
Altmann, D;
Barkhof, F;
Miszkiel, K;
Brex, PA;
O'Riordan, J;
Ebner, M;
... Chard, DT; + view all
(2020)
A thirty year clinical and MRI observational study of multiple sclerosis and clinically isolated syndromes.
Annals of Neurology
, 87
(1)
pp. 63-74.
10.1002/ana.25637.
|
Ciccarelli, O;
Cohen, JA;
Thompson, A;
(2020)
Response of the multiple sclerosis community to COVID-19.
Multiple Sclerosis Journal
, 26
(10)
pp. 1134-1136.
10.1177/1352458520948748.
|
Coetzee, T;
Thompson, AJ;
(2020)
Atlas of MS 2020: Informing global policy change.
Multiple Sclerosis Journal
10.1177/1352458520968811.
(In press).
|
Cortese, R;
Tur, C;
Prados, F;
Schneider, T;
Kanber, B;
Moccia, M;
Wheeler-Kingshott, CAMG;
... Ciccarelli, O; + view all
(2020)
Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosis.
Multiple Sclerosis Journal
10.1177/1352458519900971.
(In press).
|
Gomez, C;
Kanber, B;
Eshaghi, A;
Altmann, DR;
Khaleeli, Z;
Prados Carrasco, F;
Ourselin, S;
... Ciccarelli, O; + view all
(2020)
Clinical relevance of cortical network dynamics in early primary progressive MS.
Multiple Sclerosis Journal
, 26
(4)
pp. 442-456.
10.1177/1352458519831400.
|
Iacobaeus, E;
Arrambide, G;
Pia Amato, M;
Derfuss, T;
Vukusic, S;
Hemmer, B;
Tintore, M;
... 2018 ECTRIMS Focused Workshop Group; + view all
(2020)
Aggressive multiple sclerosis (1): Towards a definition of the phenotype.
Multiple Sclerosis Journal
, 26
(9)
pp. 1031-1044.
10.1177/1352458520925369.
|
Lublin, FD;
Coetzee, T;
Cohen, JA;
Marrie, RA;
Thompson, A;
(2020)
The 2013 clinical course descriptors for multiple sclerosis: A clarification.
Neurology
, 94
(24)
pp. 1088-1092.
10.1212/WNL.0000000000009636.
|
Moccia, M;
de Pavert, SV;
Eshaghi, A;
Haider, L;
Pichat, J;
Yiannakas, M;
Ourselin, S;
... Ciccarelli, O; + view all
(2020)
Pathologic correlates of the magnetization transfer ratio in multiple sclerosis.
Neurology
, 95
(22)
E2965-E2976.
10.1212/WNL.0000000000010909.
|
Moccia, M;
Thompson, A;
(2020)
Prompt diagnosis can improve outcomes in multiple sclerosis.
The Practitioner
, 264
(1841)
pp. 21-25.
|
Thompson, A;
Ciccarelli, O;
(2020)
Towards treating progressive multiple sclerosis.
Nature Reviews Neurology
, 16
pp. 589-590.
10.1038/s41582-020-00421-4.
|
Thompson, AJ;
Cohen, JA;
Kim, HJ;
Geurts, J;
(2020)
MSJ 2020 - Editorial comment.
Multiple Sclerosis Journal
, 26
(2)
p. 134.
10.1177/1352458519899322.
|
2019
Charalambous, T;
Tur, C;
Prados, F;
Kanber, B;
Chard, DT;
Ourselin, S;
Clayden, JD;
... Toosy, AT; + view all
(2019)
Structural network disruption markers explain disability in multiple sclerosis.
Journal of Neurology, Neurosurgery and Psychiatry
, 90
(2)
pp. 219-226.
10.1136/jnnp-2018-318440.
|
Ciccarelli, O;
Cohen, JA;
Reingold, SC;
Weinshenker, G;
(2019)
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders.
Lancet Neurology
, 18
(2)
pp. 185-197.
10.1016/S1474-4422(18)30460-5.
|
Collorone, S;
Cawley, N;
Grussu, F;
Prados, F;
Tona, F;
Calvi, A;
Kanber, B;
... Ciccarelli, O; + view all
(2019)
Reduced neurite density in the brain and cervical spinal cord in relapsing–remitting multiple sclerosis: A NODDI study.
Multiple Sclerosis Journal
10.1177/1352458519885107.
(In press).
|
David, G;
Mohammadi, S;
Martin, AR;
Cohen-Adad, J;
Weiskopf, N;
Thompson, A;
Freund, P;
(2019)
Traumatic and nontraumatic spinal cord injury: pathological insights from neuroimaging.
Nature Reviews Neurology
, 15
pp. 718-731.
10.1038/s41582-019-0270-5.
|
Eshaghi, A;
Kievit, RA;
Prados Carrasco, F;
Sudre, C;
Nicholas, J;
Cardoso, MJ;
Chan, D;
... Ciccarelli, O; + view all
(2019)
Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis.
Proceedings of the National Academy of Sciences of The United States of America (PNAS)
, 116
(22)
10.1073/pnas.1818978116.
|
Hacohen, Y;
Brownlee, W;
Mankad, K;
Chong, WK;
Thompson, AJ;
Lim, M;
Wassmer, E;
... Ciccarelli, O; + view all
(2019)
Improved performance of the 2017 McDonald criteria for diagnosis of multiple sclerosis in children with a real-life cohort.
Multiple Sclerosis Journal
10.1177/1352458519863781.
(In press).
|
Thompson, A;
Freund, P;
Seif, M;
Weiskopf, N;
Friston, K;
Fehlings, M;
Curt, A;
(2019)
MRI in traumatic spinal cord injury: from clinical assessment to neuroimaging biomarkers.
The Lancet Neurology
, 18
(12)
pp. 1123-1135.
10.1016/S1474-4422(19)30138-3.
|
Thompson, AJ;
Antel, J;
Carroll, WB;
Geurts, J;
(2019)
MSJ 2019-Editorial comment.
Multiple Sclerosis Journal
, 25
(1)
pp. 4-5.
10.1177/1352458518819096.
|
2018
Cerqueira, JJ;
Compston, DAS;
Geraldes, R;
Rosa, MM;
Schmierer, K;
Thompson, A;
Tinelli, M;
(2018)
Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?
Journal of Neurology, Neurosurgery and Psychiatry
, 89
(8)
pp. 844-850.
10.1136/jnnp-2017-317509.
|
Coetzee, T;
Thompson, AJ;
(2018)
Unified understanding of MS course is required for drug development.
Nature Reviews Neurology
, 14
pp. 191-192.
10.1038/nrneurol.2017.184.
|
Eshaghi, A;
Marinescu, RV;
Young, AL;
Firth, NC;
Prados Carrasco, F;
Cardoso, MJ;
Tur Gomez, C;
... MAGNIMS Study Group, .; + view all
(2018)
Progression of regional grey matter atrophy in multiple sclerosis.
Brain
, 141
(6)
pp. 1665-1677.
10.1093/brain/awy088.
|
Eshaghi, A;
Prados Carrasco, F;
Brownlee, W;
Altmann, DR;
Tur Gomez, C;
Cardoso, MJ;
de Angelis, F;
... Ciccarelli, O; + view all
(2018)
Deep grey matter volume loss drives disability worsening in multiple sclerosis.
Annals of Neurology
, 83
(2)
pp. 210-222.
10.1002/ana.25145.
|
Freund, P;
Thompson, A;
Curt, A;
Hupp, M;
Weiskopf, N;
Grabher, P;
Altmann, D;
... Ziegler, G; + view all
(2018)
Author response: Progressive neurodegeneration following spinal cord injury: Implications for clinical trials.
Neurology
, 91
(21)
p. 985.
10.1212/WNL.0000000000006540.
|
Huber, E;
David, G;
Thompson, AJ;
Weiskopf, N;
Mohammadi, S;
Freund, P;
(2018)
Dorsal and ventral horn atrophy is associated with clinical outcome after spinal cord injury.
Neurology
, 90
(17)
e1510-e1522.
10.1212/WNL.0000000000005361.
|
Montalban, X;
Gold, R;
Thompson, AJ;
Otero-Romero, S;
Amato, MP;
Chandraratna, D;
Clanet, M;
... Zipp, F; + view all
(2018)
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.
European Journal of Neurology
, 25
(2)
pp. 215-237.
10.1111/ene.13536.
|
Montalban, X;
Gold, R;
Thompson, AJ;
Otero-Romero, S;
Amato, MP;
Chandraratna, D;
Clanet, M;
... Zipp, F; + view all
(2018)
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis.
Multiple Sclerosis Journal
, 24
(2)
pp. 96-120.
10.1177/1352458517751049.
|
Seif, M;
Curt, A;
Thompson, AJ;
Grabher, P;
Weiskopf, N;
Freund, P;
(2018)
Quantitative MRI of rostral spinal cord and brain regions is predictive of functional recovery in acute spinal cord injury.
NeuroImage: Clinical
, 20
pp. 556-563.
10.1016/j.nicl.2018.08.026.
|
Thompson, A;
(2018)
Grand perspective on tackling motor impairment.
Presented at: 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2018, Berlin, Germany.
|
Thompson, A;
Antel, J;
Carroll, WM;
Geurts, JJG;
(2018)
2018 Editors' commentary.
[Editorial comment].
Multiple Sclerosis Journal
, 24
(11)
pp. 1394-1395.
10.1177/1352458518801764.
|
Thompson, AJ;
(2018)
Commentary on the ECTRIMS-EAN guideline for pharmacological treatment of multiple sclerosis.
Therapeutic Advances in Neurological Disorders
, 11
pp. 1-2.
10.1177/1756286418770378.
|
Thompson, AJ;
Antel, J;
Carroll, WM;
Geurts, J;
(2018)
MSJ 2018-editorial comment.
Multiple Sclerosis Journal
, 24
(2)
pp. 90-91.
10.1177/1352458518756517.
|
Thompson, AJ;
Baranzini, SE;
Geurts, J;
Hemmer, B;
Ciccarelli, O;
(2018)
Multiple sclerosis.
The Lancet
, 391
(10130)
pp. 1622-1636.
10.1016/S0140-6736(18)30481-1.
|
Thompson, AJ;
Reingold, SC;
Cohen, JA;
International Panel on Diagnosis of Multiple Sclerosis, .;
(2018)
Applying the 2017 McDonald diagnostic criteria for multiple sclerosis – Authors' reply.
The Lancet Neurology
, 17
(6)
pp. 499-500.
10.1016/S1474-4422(18)30168-6.
|
Tur, C;
Eshaghi, A;
Altmann, DR;
Jenkins, TM;
Prados, F;
Grussu, F;
Charalambous, T;
... Toosy, AT; + view all
(2018)
Structural cortical network reorganization associated with early conversion to multiple sclerosis.
Scientific Reports
, 8
, Article 10715. 10.1038/s41598-018-29017-1.
|
Tur, C;
Moccia, M;
Barkhof, F;
Chataway, J;
Sastre-Garriga, J;
Thompson, AJ;
Ciccarelli, O;
(2018)
Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting.
Nature Reviews Neurology
, 14
pp. 75-93.
10.1038/nrneurol.2017.171.
|
Ziegler, G;
Grabher, P;
Thompson, A;
Altmann, D;
Hupp, M;
Ashburner, J;
Friston, K;
... Freund, P; + view all
(2018)
Progressive neurodegeneration following spinal cord injury: Implications for clinical trials.
Neurology
, 90
(14)
e1257-e1266.
10.1212/WNL.0000000000005258.
|
2017
Bebo, B;
Fox, RJ;
Lee, K;
Utz, U;
Thompson, AJ;
(2017)
Landscape of MS patient cohorts and registries: recommendations for maximizing impact.
Multiple Sclerosis Journal
10.1177/1352458517698250.
(In press).
|
Cawley, N;
Tur, C;
Prados, F;
(2017)
Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis (vol 23, pg 1, 2017).
[Corrigendum].
Multiple Sclerosis Journal
, 23
(13)
NP30-NP30.
10.1177/1352458517717937.
|
Cawley, N;
Tur Gomez, C;
Prados Carrasco, F;
Plantone, D;
Kearney, H;
Abdel-Aziz, K;
Ourselin, S;
... Ciccarelli, O; + view all
(2017)
Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis.
Multiple Sclerosis
10.1177/1352458517709954.
(In press).
|
Coetzee, T;
Thompson, A;
(2017)
When are we going to take modifiable risk factors more seriously in multiple sclerosis?
Multiple Sclerosis Journal
, 23
(4)
pp. 494-495.
10.1177/1352458517694433.
|
Hulst, HE;
Thompson, AJ;
Geurts, JJ;
(2017)
The measure tells the tale: Clinical outcome measures in multiple sclerosis.
Multiple Sclerosis
, 23
(5)
pp. 626-627.
10.1177/1352458517690825.
|
Miller, DH;
Thompson, AJ;
(2017)
Advancing trial design in progressive multiple sclerosis.
Multiple Sclerosis Journal
, 23
(12)
pp. 1571-1572.
10.1177/1352458517729767.
|
Thompson, A;
(2017)
Multiple sclerosis: the upward trajectory continues.
[Editorial comment].
The Lancet Neurology
, 16
(1)
pp. 10-12.
10.1016/S1474-4422(16)30343-X.
|
Thompson, A;
Antel, J;
Carroll, WB;
Geurts, J;
(2017)
Editorial 2017.
[Editorial comment].
Multiple Sclerosis Journal
, 23
(1)
p. 4.
10.1177/1352458516688643.
|
Thompson, A;
Kobelt, G;
(2017)
Editorial.
Multiple Sclerosis Journal
, 23
(2)
pp. 2-3.
10.1177/1352458517708096.
|
Thompson, A;
Kobelt, G;
Berg, J;
Capsa, D;
Eriksson, J;
Miller, D;
(2017)
New insights into the burden and costs of multiple sclerosis in Europe: Results for the United Kingdom.
Multiple Sclerosis Journal
, 23
(2)
pp. 204-216.
10.1177/1352458517708687.
|
Thompson, AJ;
(2017)
Challenge of progressive multiple sclerosis therapy.
Current Opinion in Neurology
, 30
(3)
pp. 237-240.
10.1097/WCO.0000000000000453.
|
Thompson, AJ;
Banwell, BL;
Barkhof, F;
Carroll, WM;
Coetzee, T;
Comi, G;
Correale, J;
... Cohen, JA; + view all
(2017)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
The Lancet Neurology
, 17
(2)
pp. 162-173.
10.1016/S1474-4422(17)30470-2.
|
Thompson, AJ;
Kobelt, G;
Berg, J;
Gannedahl, M;
Eriksson, J;
(2017)
New insights into the burden and costs of multiple sclerosis in Europe.
Multiple Sclerosis Journal
, 23
(8)
pp. 1123-1136.
10.1177/1352458517694432.
|
Thompson, AJ;
Motl, RW;
Sandroff, BM;
Kwakkel, G;
Dalgas, U;
Feinstein, A;
Heesen, C;
(2017)
The benefits of exercise in patients with multiple sclerosis.
The Lancet Neurology
, 16
(10)
pp. 848-856.
10.1016/S1474-4422(17)30281-8.
|
Thompson, AJ;
Ontaneda, D;
Fox, RJ;
Cohen, JA;
(2017)
Progressive multiple sclerosis: Prospects for disease therapy, repair, and restoration of function.
The Lancet
, 389
(10076)
pp. 1357-1366.
10.1016/S0140-6736(16)31320-4.
|
Thompson, AJ;
Scolding, NJ;
Pasquini, M;
Reingold, SC;
Cohen, JA;
(2017)
Cell-based therapeutic strategies for multiple sclerosis.
Brain
, 140
(11)
pp. 2776-2796.
10.1093/brain/awx154.
|
2016
Ciccarelli, O;
Thompson, A;
(2016)
Multiple sclerosis in 2015: Managing the complexity of multiple sclerosis.
Nature Reviews Neurology
, 12
(2)
pp. 70-72.
10.1038/nrneurol.2016.2.
|
Eshaghi, A;
Wottschel, V;
Cortese, R;
Calabrese, M;
Sahraian, MA;
Thompson, AJ;
Alexander, DC;
(2016)
Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest.
Neurology
, 87
(23)
pp. 2463-2470.
10.1212/WNL.0000000000003395.
|
Freund, P;
Friston, K;
Thompson, AJ;
Stephan, KE;
Ashburner, J;
Bach, DR;
Nagy, Z;
... Weiskopf, N; + view all
(2016)
Embodied neurology: an integrative framework for neurological disorders.
Brain
, 139
(6)
pp. 1855-1861.
10.1093/brain/aww076.
|
Grabher, P;
Mohammadi, S;
Trachsler, A;
Friedl, S;
David, G;
Sutter, R;
Weiskopf, N;
... Freund, P; + view all
(2016)
Voxel-based analysis of grey and white matter degeneration in cervical spondylotic myelopathy.
Scientific Reports
, 6
, Article 24636. 10.1038/srep24636.
|
Marrie, RA;
Miller, A;
Sormani, MP;
Thompson, A;
Waubant, E;
Trojano, M;
O'Connor, P;
... Cohen, J; + view all
(2016)
Recommendations for observational studies of comorbidity in multiple sclerosis.
Neurology
, 86
(15)
pp. 1446-1453.
10.1212/WNL.0000000000002474.
|
Marrie, RA;
Miller, A;
Sormani, MP;
Thompson, A;
Waubant, E;
Trojano, M;
O'Connor, P;
... Cohen, JA; + view all
(2016)
The challenge of comorbidity in clinical trials for multiple sclerosis.
Neurology
, 86
(15)
pp. 1437-1445.
10.1212/WNL.0000000000002471.
|
Otero-Romero, S;
Sastre-Garriga, J;
Comi, G;
Hartung, HP;
Soelberg Sørensen, P;
Thompson, AJ;
Vermersch, P;
... Montalban, X; + view all
(2016)
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
Multiple Sclerosis Journal
, 22
(11)
pp. 1386-1396.
10.1177/1352458516643600.
|
Thompson, A;
Antel, J;
Carroll, WB;
Geurts, J;
(2016)
Editorial 2016.
Multiple Sclerosis Journal
, 22
(1)
, Article 4. 10.1177/1352458515622697.
|
Thompson, AJ;
Meijer, KA;
Muhlert, N;
Sethi, V;
Ron, MA;
Miller, DH;
Chard, D;
... Cercignani, M; + view all
(2016)
White matter tract abnormalities are associated with cognitive dysfunction and secondary progressive multiple sclerosis.
Multiple Sclerosis Journal
, 22
(11)
pp. 1429-1437.
10.1177/1352458515622694.
|
Thompson, AJ;
Zaratin, P;
Comi, G;
Coetzee, T;
Ramsey, K;
Panzara, M;
(2016)
Progressive MS Alliance Industry Forum: maximizing collective impact to enable drug development.
Trends in Pharmacological Sciences
, 37
(10)
pp. 808-810.
10.1016/j.tips.2016.07.005.
|
Tur, C;
Eshaghi, A;
Jenkins, TM;
Prados, F;
Clayden, JD;
Ourselin, S;
Altmann, DR;
... Toosy, AT; + view all
(2016)
Longitudinal changes in structural cortical networks after clinically isolated syndrome.
Presented at: 22nd Annual Meeting of the Organization for Human Brain Mapping, Geneva, Switzerland.
|
Tur, C;
Eshaghi, A;
Jenkins, TM;
Prados, F;
Clayden, JD;
Ourselin, S;
Altmann, DR;
... Toosy, AT; + view all
(2016)
Longitudinal changes in structural cortical networks after clinically isolated syndrome.
European Journal of Neurology
, 23
(S2)
, Article O1122. 10.1111/ene.13091.
|
Tur, C;
Goodkin, O;
Altmann, DR;
Jenkins, TM;
Miszkiel, K;
Mirigliani, A;
Fini, C;
... Toosy, AT; + view all
(2016)
Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis.
Brain
, 139
(3)
pp. 816-828.
10.1093/brain/awv396.
|
van de Pavert, SH;
Muhlert, N;
Sethi, V;
Wheeler-Kingshott, CA;
Ridgway, GR;
Geurts, JJ;
Ron, M;
... Ciccarelli, O; + view all
(2016)
DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime?
Journal of Neurology, Neurosurgery and Psychiatry
, 87
(5)
pp. 461-467.
10.1136/jnnp-2014-310142.
|
2015
Abdel-Aziz, K;
Schneider, T;
Solanky, BS;
Yiannakas, MC;
Altmann, DR;
Wheeler-Kingshott, CAM;
Peters, AL;
... Ciccarelli, O; + view all
(2015)
Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
Brain
, 138
(6)
pp. 1568-1582.
10.1093/brain/awv086.
|
Bodini, B;
Chard, D;
Altmann, DR;
Tozer, D;
Miller, DH;
Thompson, AJ;
Wheeler-Kingshott, CAM;
(2015)
White and grey matter damage in primary-progressive MS: the chicken or the egg?
Neurology
, 86
(2)
pp. 170-176.
10.1212/WNL.0000000000002237.
|
Cawley, N;
Solanky, BS;
Muhlert, N;
Tur, C;
Edden, RA;
Wheeler-Kingshott, CA;
Miller, DH;
... Ciccarelli, O; + view all
(2015)
Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis.
Brain
, 138
(9)
pp. 2584-2595.
10.1093/brain/awv209.
|
Grabher, P;
Callaghan, MF;
Ashburner, J;
Weiskopf, N;
Thompson, AJ;
Curt, A;
Freund, P;
(2015)
Tracking sensory system atrophy and outcome prediction in spinal cord injury.
Annals of Neurology
, 78
(5)
pp. 751-761.
10.1002/ana.24508.
|
Tur, C;
Thompson, AJ;
(2015)
Early accurate diagnosis crucial in multiple sclerosis.
Practitioner
, 259
(1785)
pp. 21-27.
|
Wottschel, V;
Alexander, DC;
Kwok, PP;
Chard, DT;
Thompson, AJ;
Miller, DH;
Ciccarelli, O;
(2015)
Predicting outcome in clinically isolated syndrome using machine learning.
NeuroImage
, 7
pp. 281-287.
10.1016/j.nicl.2014.11.021.
|
2014
Abdel-Aziz, K;
Solanky, BS;
Yiannakas, MC;
Altmann, DR;
Wheeler-Kingshott, CA;
Thompson, AJ;
Ciccarelli, O;
(2014)
Age related changes in metabolite concentrations in the normal spinal cord.
PLoS One
, 9
(10)
, Article e105774. 10.1371/journal.pone.0105774.
|
Bodini, B;
Cercignani, M;
Toosy, A;
Stefano, ND;
Miller, DH;
Thompson, AJ;
Ciccarelli, O;
(2014)
A novel approach with "skeletonised MTR" measures tract-specific microstructural changes in early primary-progressive MS.
Human Brain Mapping
, 35
(2)
pp. 723-733.
10.1002/hbm.22196.
|
Eshaghi, A;
Bodini, B;
Ridgway, GR;
García-Lorenzo, D;
Tozer, D;
Sahraian, MA;
Thompson, AJ;
(2014)
Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis.
Neuroimage
, 86
pp. 257-264.
10.1016/j.neuroimage.2013.09.059.
|
Muhlert, N;
Atzori, M;
De Vita, E;
Thomas, DL;
Samson, RS;
Wheeler-Kingshott, CA;
Geurts, JJ;
... Ciccarelli, O; + view all
(2014)
Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions.
Journal of Neurology, Neurosurgery and Psychiatry
, 85
(8)
pp. 833-839.
10.1136/jnnp-2013-306662.
|
Stroman, PW;
Wheeler-Kingshott, C;
Bacon, M;
Schwab, JM;
Bosma, R;
Brooks, J;
Cadotte, D;
... Tracey, I; + view all
(2014)
The current state-of-the-art of spinal cord imaging: methods.
Neuroimage
, 84
pp. 1070-1081.
10.1016/j.neuroimage.2013.04.124.
|
Toosy, A;
Ciccarelli, O;
Thompson, A;
(2014)
Symptomatic treatment and management of multiple sclerosis.
Handbook of Clinical Neurology
, 122
pp. 513-562.
10.1016/B978-0-444-52001-2.00023-6.
|
Toosy, AT;
Kou, N;
Altmann, D;
Wheeler-Kingshott, CAM;
Thompson, AJ;
Ciccarelli, O;
(2014)
Voxel-based cervical spinal cord mapping of diffusion abnormalities in MS-related myelitis.
Neurology
, 83
(15)
pp. 1321-1325.
10.1212/WNL.0000000000000857.
|
Tur, C;
Wheeler-Kingshott, CA;
Altmann, DR;
Miller, DH;
Thompson, AJ;
Ciccarelli, O;
(2014)
Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI.
Human Brain Mapping
, 35
(3)
993 - 1003.
10.1002/hbm.22229.
|
2013
Ciccarelli, O;
Thomas, DL;
DeVita, E;
Wheeler-Kingshott, CAM;
Kachramanoglou, C;
Kapoor, R;
Leary, S;
... Thompson, AJ; + view all
(2013)
Low Myo‐inositol indicating astrocytic damage in a case series of neuromyelitis optica.
Annals of Neurology
, 74
(2)
pp. 301-305.
10.1002/ana.23909.
|
Freund, P;
Curt, A;
Friston, K;
Thompson, A;
(2013)
Tracking changes following spinal cord injury: insights from neuroimaging.
Neuroscientist
, 19
(2)
116 - 128.
10.1177/1073858412449192.
|
Freund, P;
Weiskopf, N;
Ashburner, J;
Wolf, K;
Sutter, R;
Altmann, DR;
Friston, K;
... Curt, A; + view all
(2013)
MRI investigation of the sensorimotor cortex and the corticospinal tract after acute spinal cord injury: a prospective longitudinal study.
Lancet Neurology
, 12
(9)
pp. 873-881.
10.1016/S1474-4422(13)70146-7.
|
Hunter, RM;
Davie, C;
Rudd, A;
Thompson, A;
Walker, H;
Thomson, N;
Mountford, J;
... Morris, S; + view all
(2013)
Impact on Clinical and Cost Outcomes of a Centralized Approach to Acute Stroke Care in London: A Comparative Effectiveness Before and After Model.
PLoS One
, 8
(8)
, Article e70420. 10.1371/journal.pone.0070420.
|
Kachramanoglou, C;
De Vita, E;
Thomas, DL;
Wheeler-Kingshott, CA;
Balteau, E;
Carlstedt, T;
Choi, D;
... Ciccarelli, O; + view all
(2013)
Metabolic changes in the spinal cord after brachial plexus root re-implantation.
Neurorehabil Neural Repair
, 27
(2)
118 - 124.
10.1177/1545968312457825.
|
2012
Fox, RJ;
Thompson, A;
Baker, D;
Baneke, P;
Brown, D;
Browne, P;
Chandraratna, D;
... Zuidwijk, K; + view all
(2012)
Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS.
Multiple Sclerosis Journal
, 18
(11)
pp. 1534-1540.
10.1177/1352458512458169.
|
Freund, P;
Schneider, T;
Nagy, Z;
Hutton, C;
Weiskopf, N;
Friston, K;
Wheeler-Kingshott, CA;
(2012)
Degeneration of the injured cervical cord is associated with remote changes in corticospinal tract integrity and upper limb impairment.
PLOS One
, 7
(12)
, Article e51729. 10.1371/journal.pone.0051729.
|
Freund, P;
Wheeler-Kingshott, CA;
Nagy, Z;
Gorgoraptis, N;
Weiskopf, N;
Friston, K;
Thompson, AJ;
(2012)
Axonal integrity predicts cortical reorganisation following cervical injury.
Journal of Neurology, Neurosurgery & Psychiatry
, 83
(6)
629 -637.
10.1136/jnnp-2011-301875.
|
Marsden, J;
Ramdharry, G;
Stevenson, V;
Thompson, A;
(2012)
Muscle paresis and passive stiffness: key determinants in limiting function in Hereditary and Sporadic Spastic Paraparesis.
Gait & Posture
, 35
(2)
266 - 271.
10.1016/j.gaitpost.2011.09.018.
|
2011
Freund, P;
Weiskopf, N;
Ward, NS;
Hutton, C;
Gall, A;
Ciccarelli, O;
Craggs, M;
... Thompson, AJ; + view all
(2011)
Disability, atrophy and cortical reorganization following spinal cord injury.
Brain
, 134
(6)
1610 - 1622.
10.1093/brain/awr093.
|
Jenkins, TM;
Ciccarelli, O;
Atzori, M;
Wheeler-Kingshott, CAM;
Miller, DH;
Thompson, AJ;
Toosy, AT;
(2011)
Early pericalcarine atrophy in acute optic neuritis is associated with conversion to multiple sclerosis.
Journal of Neurology, Neurosurgery & Psychiatry
, 82
(9)
pp. 1017-1021.
10.1136/jnnp.2010.239715.
|
2010
Jenkins, T;
Toosy, AT;
Ciccarelli, O;
Miszkiel, KA;
Wheeler-Kingsnott, CA;
Henderson, AP;
Kallis, C;
... Thompson, AJ; + view all
(2010)
Reply [Neuroplasticity Predicts Outcome of Optic Neuritis Independent of Tissue Damage].
Annals of Neurology
, 68
(6)
p. 971.
10.1002/ana.22030.
|
2009
van der Linden, FAH;
Kragt, JJ;
Hobart, JC;
Klein, M;
Thompson, AJ;
van der Ploeg, HM;
Polman, CH;
(2009)
The size of the treatment effect: do patients and proxies agree?
BMC Neurology
, 9
, Article 12. 10.1186/1471-2377-9-12.
|
2008
van der Linden, FAH;
Kragt, JJ;
van Bon, M;
Klein, M;
Thompson, AJ;
van der Ploeg, HM;
Polman, CH;
(2008)
Longitudinal proxy measurements in multiple sclerosis: patient-proxy agreement on the impact of MS on daily life over a period of two years.
BMC Neurology
, 8
, Article 2. 10.1186/1471-2377-8-2.
|
2003
Dubois, B.D.;
Keenan, E.;
Porter, B.E,;
Kapoor, R.;
Rudge, P.;
Thompson, A.J.;
Miller, D.H.;
(2003)
Interferon beta in multiple sclerosis: experience in a British specialist multiple sclerosis centre.
Journal of Neurology Neurosurgery & Psychiatry
, 74
(7)
pp. 946-949.
10.1136/jnnp.74.7.946.
|
2002
Brex, P.A.;
Ciccarelli, O.;
O'Riordan, J.I.;
Sailer, M.;
Thompson, A.J.;
Miller, D.H.;
(2002)
A longitudinal study of abnormalities on MRI and disability from multiple sclerosis.
New England Journal of Medicine
, 346
(3)
pp. 158-164.
10.1056/NEJMoa011341.
|
Edwards, SGM;
Playford, ED;
Hobart, JC;
Thompson, AJ;
(2002)
Comparison of physician outcome measures and patients' perception of benefits of inpatient neurorehabilitation.
BRIT MED J
, 324
(7352)
1493 - 1493.
|